Product Code: RP-ID-10352374 |
Published Date: 21 Mar 2025 |
Region: Global |
Category: Healthcare & Pharmaceuticals |
Report ID: 10352374
Market Overview:
Closed System Transfer Devices (CSTD) Market Segmentation by Product Type (Membrane-to-Membrane, and Needleless Systems); by Component (Vial Access, Syringe Safety, and Bag/Line Access Devices, and Others); by Closing Mechanism (Push-to-Lock, Click-to-Lock, Luer Lock, and Color-to-Color Alignment System); by Technology (Diaphragm-Based, Compartmentalized, and Air Cleaning/Filtration Devices); and by End-User (Hospitals, Oncology Centers & Clinics, and Others)-Global Demand Analysis & Opportunity Outlook 2022-2031
Global Closed System Transfer Devices (CSTD) Market Highlights Over 2022 - 2031
The global closed system transfer devices (CSTD) market is estimated to garner a revenue of USD 3329.59 Million by the end of 2030 by growing at a CAGR of 16.37% over the forecast period, i.e., 2021 – 2030. Moreover, in the year 2020, the market generated a revenue of USD 735.89 Million. The growth of the market can be attributed primarily to the rising incidences of cancer globally and the growing demand for chemotherapy treatments. According to the statistics by the World Health Organization (WHO), in the year 2020, around 10 Million deaths were registered due to cancer. Closed system transfer device (CSTD) is a drug transfer device which are mainly used in chemotherapy treatments. It has been noticed that chemotherapy drugs usually are hazardous to healthcare workers. These devices mechanically prohibit surface contamination during chemotherapy treatment and therefore provides enhanced safety to the healthcare personnel as well as to the patient and their families.
CLICK TO DOWNLOAD SAMPLE REPORT
The growth of the global closed system transfer devices (CSTD) market can also be attributed to the rising number of oncology drug approvals and the surge in awareness amongst healthcare professionals regarding the hazardous nature of chemotherapy drugs. According to the statistics by the Center for Drug Evaluation and Research (CDER) of the United States Food and Drug Administration (FDA), during the period 2012 and 2021, an average of 43 novel drug approvals per year had been registered. Moreover, a total of 50 novel drug approvals were registered in the year 2021. In addition to this, the statistics also stated that in the same year, CDER approved 4 new therapies for non-small cell lung cancer. The market growth can also be attributed to the rising adoption of automated drug compounding robots, surge in application of closed system transfer devices in various therapeutic areas, rising product development, and the surge in healthcare expenditure worldwide.
Global Closed System Transfer Devices (CSTD) Market Regional Synopsis
Regionally, the global closed system transfer devices (CSTD) market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. The market in North America is anticipated to garner the largest revenue of USD 1170.35 Million by the end of 2030, up from a revenue of USD 260.21 Million in the year 2020. The growth of the market in the region can primarily be attributed to the increasing stringent government regulations for following safety protocols during the delivery of chemotherapy drugs to cancer patients, rising awareness for the hazardous nature of these drugs among the healthcare professionals, and the increasing cases of cancer in the region. According to the statistics by the National Cancer Institute, in the year 2020, it was estimated that 1806590 new cases of cancer would be diagnoses in the United States. Additionally, due to the disease, a total of 606520 people were estimated to die in the same year.
On the other hand, the market in Europe is anticipated to garner the second-largest revenue of USD 1065.80 Million by the end of 2030 and further grow with a CAGR of 16.09% during the forecast period. The market in the region is further segmented by country into Germany, the United Kingdom, Italy, France, Spain, Russia, Netherlands, and the Rest of Europe. The market in Germany is anticipated to garner the largest revenue of USD 241.83 Million by the end of 2030, up from a revenue of USD 52.76 Million in the year 2020.
Growth Drivers and Challenges Impacting the Growth of the Global Closed System Transfer Devices (CSTD) Market
Growth Drivers
-
Growing Incidence of Cancer
-
Rising Number of Oncology Drug Approvals
-
Increasing Awareness for the Hazardous Nature of Chemotherapy Drugs Among Healthcare Professionals
Challenges
• Lack of Uniform Technical Regulations
Global Closed System Transfer Devices (CSTD) Market Segmentation Synopsis
The global closed system transfer devices (CSTD) market is segmented on the basis of product type into membrane-to-membrane systems, and needleless systems, out of which, the membrane-to-membrane systems segment is anticipated to garner the largest revenue by the end of 2030 and grow with a CAGR of 15.91% during the forecast period. By component, the market is further segmented into vial access devices, syringe safety devices, bag/line access devices, and others. Out of these, the vial access devices segment is anticipated to garner the largest revenue of USD 1169.75 Million by the end of 2030, up from a revenue of USD 261.20 Million in the year 2020. By closing mechanism, the market is segmented into the push-to-lock system, click-to-lock system, Luer lock system, and color-to-color alignment system. Out of these, the push-to-lock system segment is expected to grow with a CAGR of 16.09% during the forecast period and attain a revenue of USD 1186.79 Million by the end of 2030. On the basis of technology, the market is segmented into diaphragm-based devices, compartmentalized devices, and air cleaning/filtration devices. Out of these, the diaphragm-based devices segment is anticipated to garner the largest revenue of USD 1596.88 Million by the end of 2030, up from a revenue of USD 358.07 Million in the year 2020. By end-user, the market is segmented into hospitals, oncology centers & clinics, and others. Out of these, the hospitals segment generated the largest revenue of USD 551.27 Million in the year 2020 and is further expected to touch USD 2550.61 Million by the end of 2030.
Key Companies Dominating the Market
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global closed system transfer devices (CSTD) market that are included in our report are Becton, Dickinson and Company, Yukon Medical, LLC, Caragen Ltd., ICU Medical, Inc., Vygon, JMS North America Corporation, CODAN Companies, Corvida Medical, EquashieldMedical Ltd., and others.
Latest Developments in the Global Closed System Transfer Devices (CSTD) Market:
-
April 7th, 2021: Simplivia Healthcare Ltd. announced that it has launched its newest CSTD named Chemfort at the European Association of Hospital Pharmacists (EAHP) Congress 2021. The product, which was recently awarded the U.S. FDA product code ONB provides enhanced usability and incorporates the Toxi-Guard patent technology of the company.
-
November 8th, 2021: Corvida Medical announced that it has signed an exclusive distribution agreement with the global healthcare company, Fresenius Kabi for the exclusive distributorship of the HALO closed system drug transfer device (CSTD) in the United States.
Key Reasons to Buy Our Report
-
The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.
-
It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.
-
The report includes detailed company profiles of the major players dominating the market.
-
We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
-
We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.
- Becton, Dickinson, and Company
- Yukon Medical, LLC
- Caragen Ltd.
- ICU Medical, Inc.
- Vygon
- JMS North America Corporation
- CODAN Companies
- Corvida Medical
- Simplivia Healthcare Ltd.
- EquashieldMedical Ltd.
Related Reports
Proof of Quality & Reliability
